Changes in long term survival after diagnosis with common hematologic malignancies in the early 21st century

Five-year survival has increased for many hematologic malignancies in the 21st century. However, whether this has translated into greater long-term survival is unknown. Here, we examine 10- and 20-year survival for patients with multiple myeloma (MM), acute lymphoblastic leukemia (ALL), acute myelob...

Descripción completa

Detalles Bibliográficos
Autores principales: Pulte, Dianne, Jansen, Lina, Brenner, Hermann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7221083/
https://www.ncbi.nlm.nih.gov/pubmed/32404891
http://dx.doi.org/10.1038/s41408-020-0323-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7221083/
https://www.ncbi.nlm.nih.gov/pubmed/32404891
http://dx.doi.org/10.1038/s41408-020-0323-4

Ejemplares similares